{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:10:09Z","timestamp":1779916209798,"version":"3.53.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128310","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:42:18Z","timestamp":1771360938000},"page":"128310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024"],"prefix":"10.1016","volume":"77","author":[{"given":"Nicholas","family":"Amoako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Cohuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Rockson","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Gurry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Oduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince Darko","family":"Agyapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osei","family":"Musah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy Asantewaa","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Afum-Adjei","family":"Awuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Ayivor-Djanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwabena Obeng","family":"Duedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Kenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Obeng","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Owusu-Dabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Amuasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Asiedu-Bekoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Laryea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Kasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Ann","family":"Ohene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.C.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worwui Kwame","family":"Archibald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Ampofo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Owusu-Agyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Mathiu","family":"Mwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaku Poku","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128310_bb0005","unstructured":"WHO. Coronavirus disease (COVID-19) pandemic. Available at: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019. Accessed March 21, 2024."},{"key":"10.1016\/j.vaccine.2026.128310_bb0010","unstructured":"World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. WHO https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"issue":"21","key":"10.1016\/j.vaccine.2026.128310_bb0015","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2020.5460","article-title":"Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions","volume":"323","author":"Gostin","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128310_bb0020","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268822001212","article-title":"COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward","volume":"150","author":"Impouma","year":"2022","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2026.128310_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Sig Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128310_bb0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Andreadakis","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2026.128310_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2021.07.003","article-title":"COVID-19 vaccines","volume":"71","author":"Ndwandwe","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2026.128310_bb0040","unstructured":"Gurry C, Mwenda JM, Nardone A, and the AFRO-MoVE Network. Establishing the African region monitoring vaccine effectiveness (AFRO-MoVE) network for respiratory pathogens. Under review. Vacc J Suppl."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128310_bb0045","article-title":"One year after first case of COVID-19 in Ghana: epidemiology, challenges and accomplishments","volume":"39","author":"Amponsah","year":"2021","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.vaccine.2026.128310_bb0050","doi-asserted-by":"crossref","unstructured":"Christopher Sunkwa Tamal, Sally-Ann Ohene, Rafiq Nii Okine, Michael Adjabeng, Argata Guracha Guyo, Fred Osei-Sarpong, Patrick Avevor, Ama Akyampoma Owusu Asare, Franklin Asiedu-Bekoe, Gideon Kwarteng, Patrick Kuma-Aboagye, Francis Chisaka Kasolo. Examining the Evolution and Drivers of COVID-19 Transmission Waves in Ghana, 2020\u20132022.medRxiv preprint doi:https:\/\/doi.org\/10.1101\/2023.07.17.23292790.","DOI":"10.1101\/2023.07.17.23292790"},{"key":"10.1016\/j.vaccine.2026.128310_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/20420986221116452","article-title":"Safety surveillance and challenges in accelerated COVID-19 vaccine development","volume":"13","author":"Cole","year":"2022","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128310_bb0060","first-page":"47","article-title":"The importance of monitoring adherence to vaccinations of different population groups in the structure of the information subsystem of epidemiological surveillance of vaccine prevention","volume":"9","author":"Platonova","year":"2019","journal-title":"Epidemiol Infect Dis Curr Items"},{"key":"10.1016\/j.vaccine.2026.128310_bb0065","series-title":"WHO vaccine-preventable diseases: monitoring system: 2009 global summary","author":"World Health Organization","year":"2009"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128310_bb0070","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","article-title":"Protection and waning of natural and hybrid immunity to SARS-CoV-2","volume":"386","author":"Goldberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.vaccine.2026.128310_bb0075","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128310_bb0080","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.2147\/IDR.S369769","article-title":"Durability of SARS-CoV-2 specific IgG antibody responses following two doses of match and mixed COVID-19 vaccines regimens in Saudi population","volume":"15","author":"Mubarak","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128310_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2022.115803","article-title":"SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays","volume":"104","author":"Meyers","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128310_bb0090","article-title":"Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 omicron variant","volume":"3","author":"Lyke","year":"2022","journal-title":"Cell Rep Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128310_bb0095","doi-asserted-by":"crossref","DOI":"10.2196\/24341","article-title":"Influenza and respiratory virus surveillance, vaccine uptake, and effectiveness at a time of cocirculating COVID-19: protocol for the English primary care sentinel system for 2020-2021","volume":"7","author":"De Lusignan","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2026.128310_bb0100","series-title":"WHO Interim Global Epidemiological Surveillance Standards for Influenza (July 2012)","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2026.128310_bb0105","doi-asserted-by":"crossref","unstructured":"PA Harris, R Taylor, R Thielke, J Payne, N Gonzalez, JG. Conde, Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform 2009;42(2):377\u201381.","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"10.1016\/j.vaccine.2026.128310_bb0110","doi-asserted-by":"crossref","unstructured":"PA Harris, R Taylor, BL Minor, V Elliott, M Fernandez, L O'Neal, L McLeod, G Delacqua, F Delacqua, J Kirby, SN Duda, REDCap consortium, the REDCap consortium: Building an international community of software partners, J Biomed Inform 2019[doi:https:\/\/doi.org\/10.1016\/j.jbi.2019.103208].","DOI":"10.1016\/j.jbi.2019.103208"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128310_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2471\/BLT.17.194514","article-title":"Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection","volume":"96","author":"Fitzner","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128310_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000867","article-title":"Detection of SARS-CoV-2 RNA by multiplex RT-qPCR","volume":"18","author":"Kudo","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2026.128310_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104499","article-title":"Multiplexing primer\/probe sets for detection of SARS-CoV-2 by qRT-PCR","volume":"129","author":"Perchetti","year":"2020","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128310_bb0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4269\/ajtmh.22-0469","article-title":"COVID-19 in 16 west African countries: an assessment of the epidemiology and genetic diversity of SARS-CoV-2 after four epidemic waves","volume":"109","author":"Ndiaye","year":"2023","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128310_bb0135","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128310_bb0140","unstructured":"Evaluation of Waning of SARS-CoV-2 Vaccine\u2013Induced Immunity. A Systematic Review and Meta-analysis;https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2804451."},{"key":"10.1016\/j.vaccine.2026.128310_bb0145","unstructured":"Ghana Health Service. Ghana's Outbreak Response Management Updates: Ghana Health Service, 2021. Available: https:\/\/ghanahealthservice.org\/covid19\/archive.php [Accessed 3 Feb 2021."},{"issue":"5","key":"10.1016\/j.vaccine.2026.128310_bb0150","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/vaccines10050736","article-title":"Percentages of vaccination coverage required to establish herd immunity against SARS-CoV-2","volume":"10","author":"Plans-Rubi\u00f3","year":"2022","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128310_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.21.287516","article-title":"COVAX and equitable access to COVID-19 vaccines","volume":"100","author":"Yoo","year":"2022","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2026.128310_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.626852","article-title":"Hesitation and refusal factors in individuals\u2019 decision-making processes regarding a coronavirus disease 2019 vaccination","volume":"9","author":"Cerda","year":"2021","journal-title":"Front Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128310_bb0165","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1177\/1049732320933863","article-title":"The factors that promote vaccine hesitancy, rejection, or delay in parents","volume":"30","author":"Majid","year":"2020","journal-title":"Qual Health Res"},{"key":"10.1016\/j.vaccine.2026.128310_bb0170","article-title":"COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European region (2022\u22122023): a test-negative case-control study from the EuroSAVE network","volume":"47","author":"Katz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"15","key":"10.1016\/j.vaccine.2026.128310_bb0175","doi-asserted-by":"crossref","first-page":"2400178","DOI":"10.2807\/1560-7917.ES.2024.29.15.2400178","article-title":"Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024","volume":"29","author":"N\u00f8rgaard","year":"2024","journal-title":"Eurosurveillance"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128310_bb0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-2600(23)00414-9","article-title":"The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia","volume":"12","author":"Catal\u00e0","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2026.128310_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071502","article-title":"Effectiveness of a fourth dose of COVID-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study","volume":"378","author":"Grewal","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2026.128310_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2022.03.028","article-title":"Waning COVID-19 vaccine effectiveness for BNT162b2 and CoronaVac in Malaysia: an observational study","volume":"119","author":"Suah","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2026.128310_bb0195","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128310_bb0200","article-title":"Waning of vaccine effectiveness against moderate and severe COVID-19 among adults in the US from the VISION network: test negative, case-control study","volume":"379","author":"Ferdinands","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2026.128310_bb0205","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7107e2","volume":"71","author":"Ferdinands","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"10.1016\/j.vaccine.2026.128310_bb0210","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning immunity after the BNT162b2 vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128310_bb0215","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1473-3099(22)00146-3","article-title":"COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID study","volume":"22","author":"Menni","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128310_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ccell.2021.11.006","article-title":"Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer","volume":"40","author":"Shapiro","year":"2022","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128310_bb0225","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/14649373.2020.1832300","article-title":"Ghana in COVID-19 pandemic","volume":"21","author":"Khoo","year":"2020","journal-title":"Inter-Asia Cult Stud"},{"issue":"08","key":"10.1016\/j.vaccine.2026.128310_bb0230","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3855\/jidc.12909","article-title":"COVID-19 pandemic in resource-poor countries: challenges, experiences and opportunities in Ghana","volume":"14","author":"Afriyie","year":"2020","journal-title":"J Infect Devel Countries"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:31:16Z","timestamp":1779913876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":46,"alternative-id":["S0264410X26001180"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128310","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128310"}}